- US-listed companies
- APPLIED DNA SCIENCES INC
APPLIED DNA SCIENCES INCAPDN
Market cap
P/E ratio
Sep 30, 2011 | Sep 30, 2019 | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | |
Cash and cash equivalents | 3 | 558,988 | 8 | 7 | 15 |
Accounts Receivable, Net, Current, Total | 208,587 | 839,951 | 194,319 | 3 | 3 |
Inventories | - | 142,629 | 497,367 | 1 | 602,244 |
Prepaid expenses and other current assets | - | 604,740 | 599,296 | 568,881 | 1 |
Total current assets | 3 | 2 | 9 | 11 | 20 |
Property and equipment, net | 89,108 | 226,221 | 1 | 3 | 2 |
Deposits | - | 62,351 | 95,083 | 95,040 | 98,997 |
Total assets | 4 | 4 | 11 | 14 | 22 |
Accounts payable and accrued liabilities | 768,061 | 2 | 2 | 3 | 4 |
Deferred revenue | - | 628,993 | 511,036 | 281,000 | 563,557 |
Total current liabilities | 4 | 2 | 4 | 3 | 4 |
Long term accrued liabilities | - | 621,970 | 848,307 | 31,467 | 31,467 |
Common Warrant liability | - | - | - | - | 5 |
Total liabilities | - | 4 | 6 | 3 | 9 |
Common Stock, Value, Issued | 473,326 | 1,200 | 5,144 | 7,488 | 12,909 |
Additional paid in capital | 160 | 256 | 276 | 295 | 305 |
Accumulated deficit | -161,856,427 | -256,805,589 | -269,835,650 | -284,122,092 | -292,500,088 |
Applied DNA Sciences, Inc. stockholders' equity: | -995,385 | -841,459 | 6 | 11 | 13 |
Noncontrolling interest | - | -7,040 | -8,725 | -722 | -2,890 |
Total equity | - | -848,499 | 6 | 11 | 13 |
Total liabilities and equity | 4 | 4 | 11 | 14 | 22 |